Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (4)
- (-) Frontier (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Big Data (1)
- Bioenergy (9)
- Biology (14)
- Biomedical (6)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (2)
- Clean Water (3)
- Climate Change (3)
- Computer Science (14)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (5)
- Environment (21)
- Exascale Computing (2)
- Fusion (1)
- Grid (1)
- High-Performance Computing (9)
- Isotopes (6)
- ITER (1)
- Materials (4)
- Materials Science (6)
- Mercury (3)
- Microscopy (3)
- Nanotechnology (3)
- National Security (4)
- Neutron Science (6)
- Nuclear Energy (4)
- Physics (2)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (4)
- Security (2)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (7)
- Transportation (6)
Media Contacts
![U.S. Secretary of Energy Granholm tours ORNL’s world-class science facilities](/sites/default/files/styles/list_page_thumbnail/public/2021-11/2021-P09409.jpg?h=036a71b7&itok=C8b0_-Vk)
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Deborah%20Frincke%20profile_0.jpg?h=8caed45b&itok=0eTC4gMH)
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
![ORNL’s Sergei Kalinin and Rama Vasudevan (foreground) use scanning probe microscopy to study bulk ferroelectricity and surface electrochemistry -- and generate a lot of data. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/KalininVasudevan_2017-P03014_0.jpg?h=1116cd87&itok=KEEOB4hi)
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.